Notice: This company has been marked as potentially delisted and may not be actively trading. HealthCor Catalio Acquisition (HCAQ) Competitors Add Compare Share Share Competitors Stock AnalysisCompetitorsTrends HCAQ vs. CHEK, GEHC, PHG, HOLX, BFLY, NNOX, XFOR, DERM, EPRX, and IVCPShould you be buying HealthCor Catalio Acquisition stock or one of its competitors? The main competitors of HealthCor Catalio Acquisition include Check-Cap (CHEK), GE HealthCare Technologies (GEHC), Koninklijke Philips (PHG), Hologic (HOLX), Butterfly Network (BFLY), Nano-X Imaging (NNOX), X4 Pharmaceuticals (XFOR), Journey Medical (DERM), Eupraxia Pharmaceuticals (EPRX), and Swiftmerge Acquisition (IVCP). HealthCor Catalio Acquisition vs. Check-Cap GE HealthCare Technologies Koninklijke Philips Hologic Butterfly Network Nano-X Imaging X4 Pharmaceuticals Journey Medical Eupraxia Pharmaceuticals Swiftmerge Acquisition Check-Cap (NASDAQ:CHEK) and HealthCor Catalio Acquisition (NASDAQ:HCAQ) are both small-cap medical companies, but which is the better investment? We will contrast the two businesses based on the strength of their community ranking, valuation, dividends, institutional ownership, risk, media sentiment, profitability, analyst recommendations and earnings. Does the media favor CHEK or HCAQ? In the previous week, Check-Cap had 3 more articles in the media than HealthCor Catalio Acquisition. MarketBeat recorded 3 mentions for Check-Cap and 0 mentions for HealthCor Catalio Acquisition. Check-Cap's average media sentiment score of 0.29 beat HealthCor Catalio Acquisition's score of 0.00 indicating that Check-Cap is being referred to more favorably in the media. Company Overall Sentiment Check-Cap Neutral HealthCor Catalio Acquisition Neutral Which has better earnings and valuation, CHEK or HCAQ? CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioCheck-CapN/AN/A-$17.57M-$3.00-0.34HealthCor Catalio AcquisitionN/AN/AN/AN/AN/A Do institutionals and insiders believe in CHEK or HCAQ? 1.1% of Check-Cap shares are owned by institutional investors. Comparatively, 84.2% of HealthCor Catalio Acquisition shares are owned by institutional investors. 0.5% of Check-Cap shares are owned by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock will outperform the market over the long term. Is CHEK or HCAQ more profitable? Company Net Margins Return on Equity Return on Assets Check-CapN/A N/A N/A HealthCor Catalio Acquisition N/A N/A N/A Does the MarketBeat Community prefer CHEK or HCAQ? Check-Cap received 370 more outperform votes than HealthCor Catalio Acquisition when rated by MarketBeat users. CompanyUnderperformOutperformCheck-CapOutperform Votes37062.18% Underperform Votes22537.82% HealthCor Catalio AcquisitionN/AN/A SummaryCheck-Cap beats HealthCor Catalio Acquisition on 4 of the 5 factors compared between the two stocks. Get HealthCor Catalio Acquisition News Delivered to You Automatically Sign up to receive the latest news and ratings for HCAQ and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart HCAQ vs. The Competition Export to ExcelMetricHealthCor Catalio AcquisitionX IndustryMedical SectorNASDAQ ExchangeMarket Cap$21.10M$13.72B$5.62B$9.14BDividend YieldN/A1.82%5.36%3.98%P/E RatioN/A24.6089.6917.66Price / SalesN/A14.421,222.3481.23Price / CashN/A12.8144.3437.71Price / BookN/A2.785.134.73Net IncomeN/A$170.54M$118.85M$225.42M HealthCor Catalio Acquisition Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)HCAQHealthCor Catalio AcquisitionN/A$0.99-2.0%N/A+2.0%$21.10MN/A0.002CHEKCheck-Cap0.2151 of 5 stars$1.19-8.5%N/A-53.1%$6.96MN/A-0.4080Analyst ForecastShort Interest ↑GEHCGE HealthCare Technologies2.7342 of 5 stars$88.99+0.4%$96.00+7.9%+18.1%$40.51B$19.56B24.4551,000Short Interest ↑Positive NewsPHGKoninklijke Philips2.2631 of 5 stars$27.31+1.6%N/A+26.9%$25.26B$18.04B-65.0369,656HOLXHologic4.8096 of 5 stars$72.81+2.5%$88.92+22.1%-4.8%$16.43B$4.03B21.867,063Upcoming EarningsShort Interest ↑BFLYButterfly Network0.9892 of 5 stars$3.61-7.6%$3.00-16.8%+228.5%$768.08M$65.90M-7.84460News CoverageGap DownNNOXNano-X Imaging2.2856 of 5 stars$7.50-9.0%$17.50+133.3%+27.1%$433.35M$9.90M-8.82190Positive NewsGap DownXFORX4 Pharmaceuticals4.3236 of 5 stars$0.49+3.0%$3.50+612.0%-13.3%$83.84MN/A-5.4680Gap UpDERMJourney Medical2.689 of 5 stars$3.98-4.3%$9.38+135.6%N/A$83.14M$79.18M-4.2390Short Interest ↑News CoverageEPRXEupraxia Pharmaceuticals3.5318 of 5 stars$3.02+3.1%$9.00+198.0%N/A$82.39MN/A-4.1929Gap UpIVCPSwiftmerge AcquisitionN/A$12.00-9.0%N/A+8.6%$82.08MN/A-600.002,021News CoverageGap Down Related Companies and Tools Related Companies CHEK Competitors GEHC Competitors PHG Competitors HOLX Competitors BFLY Competitors NNOX Competitors XFOR Competitors DERM Competitors EPRX Competitors IVCP Competitors Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (NASDAQ:HCAQ) was last updated on 1/30/2025 by MarketBeat.com Staff From Our PartnersHas Trump finally met his match?Dylan Jovine predicted the 2008 crash over a year before it happened. Folks who listened to him had the chance...Behind the Markets | SponsoredI was wrong. Dead wrong. I thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was. Because here we...Porter & Company | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowCrypto has officially entered the "banana zone" – that wild phase where prices can 1000x in days. It happen...Crypto Swap Profits | SponsoredAlert: DOGE goes live"It's Elon's world, and the rest of us live in it." Every investor in America is trying to figure out what ...Altimetry | SponsoredBuy NVDA Now? After weeks of volatility, did President Trump just turn Nvidia (NVDA) into a raging BUY? The beloved chip...Chaikin Analytics | Sponsored Is Starlink Set For The Largest IPO In History?He turned PayPal from a tiny, off-the-radar startup… to a massive $64 billion giant. Then, he did it again ...Paradigm Press | SponsoredTrump vs. TexasEver since Donald Trump won the election, U.S. states have been rushing to pass new currency rules. These r...Stansberry Research | SponsoredTrump’s New AI Move Could Trigger Massive Melt UPIn his first week in office, President Trump already revoked President Biden's disastrous AI executive order.....InvestorPlace | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding HealthCor Catalio Acquisition Corp. Please log in to your account or sign up in order to add this asset to your watchlist. Share HealthCor Catalio Acquisition With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free HCAQ Stock Alerts